5-Bromouracil → 5-morpholinopyrimidine-2,4(1H,3H)-dione
Reaction equation
Br[C:2]1[C:3](=[O:9])[NH:4][C:5](=[O:8])[NH:6][CH:7]=1.[NH:10]1[CH2:15][CH2:14][O:13][CH2:12][CH2:11]1>>[O:13]1[CH2:14][CH2:15][N:10]([C:2]2[C:3](=[O:9])[NH:4][C:5](=[O:8])[NH:6][CH:7]=2)[CH2:11][CH2:12]1Participants
3
Procedure
The title compound was obtained according to the procedure described for the synthesis of Example 10 (Step1), starting from 5-bromouracil (0.10 g, 052 mmol) and 20 equivalents of morpholine. The crude was purified by precipitation in acidic water (10 mL, pH 5) to afford the title compound (0.08 g, 76%) as white, powder. 1H NMR (400 MHz, DMSO-d6): δ 2.74-2.84 (m, 4H), 3.64 (t, J=4.6 Hz, 4H), 6.72 (s, 1H), 10.47 (s, 1H), 11.05 (s, 1H).
Workup
- customdescribed for the synthesis of Example 10 (Step1)
- customThe crude was purified by precipitation in acidic water (10 mL, pH 5)
Sources & evidence
- ORD record
- ord-2b5546c8874643589e7805d438fb11bd
- Source dataset
- uspto-grants-2016_08
- Patent number
- US09428465B2
Reaction notes
Loading…